ProfileGDS4718 / 205782_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 13% 16% 67% 8% 14% 7% 15% 12% 18% 12% 4% 13% 11% 10% 14% 9% 14% 14% 10% 14% 14% 13% 14% 20% 8% 13% 10% 13% 13% 11% 9% 19% 11% 10% 15% 15% 5% 25% 12% 76% 13% 14% 19% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8996913
GSM549102patient 115, normal, homogenized [OPG study]4.0239616
GSM549104patient 119, normal, homogenized [OPG study]6.6601467
GSM549108patient 138, normal, homogenized [OPG study]3.737068
GSM549119patient 077, normal, homogenized [OPG study]3.9331914
GSM549133patient 032, cancer, homogenized [OPG study]3.636137
GSM549139patient 042, cancer, homogenized [OPG study]3.9370115
GSM549099patient 107, normal, homogenized [OPG study]3.8476212
GSM549109patient 139, normal, homogenized [OPG study]4.0842918
GSM549110patient 046, normal, homogenized [OPG study]3.8501512
GSM549114patient 063, normal, homogenized [OPG study]3.528444
GSM549122patient 082, normal, homogenized [OPG study]3.9073713
GSM549134patient 033, cancer, homogenized [OPG study]3.8329711
GSM549136patient 036, cancer, homogenized [OPG study]3.7332910
GSM549140patient 044, cancer, homogenized [OPG study]3.8772914
GSM549111patient 047, normal, homogenized [OPG study]3.736889
GSM549113patient 057, normal, homogenized [OPG study]3.8756814
GSM549132patient 031, cancer, homogenized [OPG study]3.9315114
GSM549137patient 038, cancer, homogenized [OPG study]3.7847910
GSM549142patient 047, cancer, homogenized [OPG study]4.0144614
GSM549100patient 110, normal, homogenized [OPG study]3.9448514
GSM549107patient 135, normal, homogenized [OPG study]3.8718213
GSM549115patient 068, normal, homogenized [OPG study]3.8857114
GSM549116patient 072, normal, homogenized [OPG study]4.1353220
GSM549120patient 078, normal, homogenized [OPG study]3.702798
GSM549131patient 030, cancer, homogenized [OPG study]3.8620313
GSM549118patient 074, normal, homogenized [OPG study]3.7776310
GSM549129patient 027, cancer, homogenized [OPG study]3.8944413
GSM549123patient 088, normal, homogenized [OPG study]3.9012913
GSM549124patient 006, cancer, homogenized [OPG study]3.8342511
GSM549126patient 015, cancer, homogenized [OPG study]3.723789
GSM549128patient 025, cancer, homogenized [OPG study]4.0749219
GSM549103patient 117, normal, homogenized [OPG study]3.8342511
GSM549117patient 073, normal, homogenized [OPG study]3.7815710
GSM549138patient 041, cancer, homogenized [OPG study]3.9554815
GSM549141patient 045, cancer, homogenized [OPG study]3.9148415
GSM549130patient 028, cancer, homogenized [OPG study]3.593125
GSM549101patient 111, normal, homogenized [OPG study]4.3366725
GSM549105patient 128, normal, homogenized [OPG study]3.8768612
GSM549106patient 134, normal, homogenized [OPG study]7.5732376
GSM549112patient 048, normal, homogenized [OPG study]3.8673113
GSM549125patient 011, cancer, homogenized [OPG study]3.9208214
GSM549127patient 024, cancer, homogenized [OPG study]4.0972619
GSM549135patient 035, cancer, homogenized [OPG study]3.8285613